4//SEC Filing
Klingensmith Harvey Robert 4
Accession 0000950170-25-049169
CIK 0001958086other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 2:37 PM ET
Size
8.7 KB
Accession
0000950170-25-049169
Insider Transaction Report
Form 4
Klingensmith Harvey Robert
Director
Transactions
- Award
Restricted Shares
2025-04-01+8,069→ 8,069 totalExercise: $0.00→ Common Stock (8,069 underlying) - Exercise/Conversion
Common Stock
2025-04-01+9,317→ 41,962 total - Exercise/Conversion
Restricted Shares
2025-04-01−9,317→ 0 totalExercise: $0.00→ Common Stock (9,317 underlying)
Footnotes (2)
- [F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance.
- [F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.
Documents
Issuer
Core Laboratories Inc. /DE/
CIK 0001958086
Entity typeother
Related Parties
1- filerCIK 0001800107
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 2:37 PM ET
- Size
- 8.7 KB